Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 4, 1999
View Archived Issues
Innogenetics reaches new LiPA agreement with Abbott
Read More
New antiulcer drug expected to reach Spanish market later this year
Read More
Patient accrual completed for phase III trial of Onconase
Read More
BioMarin completes financing, gears up to file first BLA
Read More
Kinetix prepares to accelerate protein kinase inhibitor drug discovery programs
Read More
Company Profile: Dynamis Therapeutics
Read More
Advanced Magnetics: Q2 1999 highlights
Read More
Licensing opportunity from LG Chemical: broad-spectrum catechol-substituted cephalosporin
Read More
PathoGenesis: Q1 1999 highlights
Read More
InSite Vision signs agreement with U. of California for glaucoma gene rights
Read More
Adenosine reduces complications in CABG
Read More
Company Profile: TheRyte
Read More
Subcutaneous anti-CD3 antibody enters psoriasis trial
Read More
BMS files for approval of new indication for paclitaxel
Read More
Unimed submits NDA for Androgel
Read More
Guilford: Annual Report 1998
Read More
Azolidinedione derivatives for improving insulin resistance
Read More
Potent and selective COX-2 inhibitors in the Glaxo Wellcome pipeline
Read More
Elastase inhibitors synthesized at Glaxo Wellcome, useful for chronic bronchitis
Read More
New carbapenems with good activity against resistant Gram-positive bacteria developed at Merck
Read More
Serine protease inhibitors designed at Glaxo Wellcome
Read More
Incyte discovers novel human tumor suppressor with application in cancer, autoimmune diseases
Read More
Anti-CCR5 MAb acts as potent HIV inhibitor
Read More
Former Novo Nordisk research unit now operating as independent company
Read More
FDA approves UroCor's prostate cancer radiation implants
Read More
Development of novel antiischemic drugs at Cypros funded by NIH
Read More
Novel benzylhydroxylamine with potent and selective anti-HIV activity undergoes further testing
Read More
New epibatidine analogues with antinociceptive activity and novel mechanism of action
Read More
Takeda initiates clinical testing with osteogenesis-promoting agent
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe